OnKure Therapeutics, Inc. Share Price & Technical Analysis
OKUR · $4.29 (+1.66%)
Healthcare / Biotechnology
$4.29
+1.66%
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment…
Price chart
Seasonality
Jun has 1 positive and 3 negative years (last 5 years shown)
0% return in Jun, -10% avg return in past 3 year Jun month.
54% return in 2026, -14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | 4% | 52% | 29% | -21% | 0% | – | – | – | – | – | – | 54% |
| 25 | -29% | -16% | -17% | -42% | 4% | -4% | -8% | 27% | 4% | 26% | -12% | -3% | -71% |
| 24 | 2% | 1% | 3% | 1% | -1% | -9% | -3% | 1% | 16% | 4% | -10% | -44% | -40% |
| 23 | 14% | 15% | 94% | 70% | -24% | -18% | 9% | -25% | 24% | 6% | -22% | -75% | 69% |
| 22 | -28% | -23% | -37% | -22% | -12% | 23% | 35% | -11% | -4% | 4% | -35% | -3% | -114% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$174.51M
P/E ratio
—
52W high
$5.38
52W low
$1.91
Volume
1,67,800
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is OnKure Therapeutics, Inc. share price today?
- OnKure Therapeutics, Inc. (OKUR) last traded around $4.29 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does OKUR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for OKUR. Download the app for real-time alerts.
- How can I analyze OnKure Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.